Regional

Old Dominion EMS Alliance, Inc.

Current190 dose entries41 drugs8 documentsHenrico, VAeffective 2026-06-1799% machine-parsed of 190

Old Dominion EMS Alliance, Inc. (Henrico, VA) carries 41 drugs across 190 dose entries in its current published protocol, effective 2026-06-17.

Drugs and doses41

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	page 458
SVT	peds	0.1 mg/kg	IV	not captured	standing	page 458

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	1-2 inhalations	MDI	not captured	standing	page 460
Asthma / bronchospasm	adult	5 mg	NEB	not captured	standing	page 460
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 460

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	150 mg	IV	not captured	standing	page 462
Wide-complex tachycardia	adult	300 mg	IV	not captured	standing	page 462
Wide-complex tachycardia	peds	5 mg/kg	IV	not captured	standing	page 462
Wide-complex tachycardia	peds	5 mg/kg	IV	not captured	standing	page 462
VF / pulseless VT	adult	300 mg	IV	not captured	standing	page 462
VF / pulseless VT	peds	5 mg/kg	IV	not captured	standing	page 462

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 464
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 464

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5–1 mg	IV	not captured	standing	page 466
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	page 466
Organophosphate poisoning	adult	1–2 mg	IV	not captured	standing	page 466
Organophosphate poisoning	peds	0.05 mg/kg	IV	not captured	standing	page 466

Bumetanide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	1–2 mg	IV	not captured	standing	page 470
CHF / pulmonary edema	adult	1–2 mg	IV	not captured	standing	page 470
Other	adult	1–2 mg	IV	not captured	standing	page 470

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV	not captured	standing	page 472
Hyperkalemia	peds	20 mg/kg	IV	not captured	standing	page 472
Other	peds	20 mg/kg	IV	not captured	standing	page 472

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	10 mg	IV/IM/PO	not captured	standing	page 141
Asthma / bronchospasm	peds	0.6 mg/kg	IV/IM/PO	not captured	standing	page 141
Croup	adult	10 mg	IV/IM/PO	not captured	standing	page 324
Croup	peds	0.6 mg/kg	IV/IM/PO	not captured	standing	page 324

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mL	IV/IO	not captured	standing	page 476
Hypoglycemia	peds	2 mL/kg	IV/IO	not captured	standing	page 476

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2.5–5 mg	IV	not captured	standing	page 66
Agitation	adult	2.5–5 mg	IV/IM	not captured	standing	page 115
Seizure	adult	2.5–5 mg	IV	not captured	standing	page 145
Seizure	peds	0.25 mg/kg	IV	not captured	standing	page 145

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	0.25 mg/kg	IV	not captured	standing	page 484
Atrial fibrillation with RVR	peds	1 mcg/kg	IV	not captured	standing	page 484
SVT	adult	0.25 mg/kg	IV	not captured	standing	page 484
SVT	peds	1 mcg/kg	IV	not captured	standing	page 484

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 110
Allergic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 486
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 110
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 486
Anaphylaxis	adult	25–50 mg	IV/IM	not captured	standing	page 110
Anaphylaxis	peds	1 mg/kg	IV/IM	not captured	standing	page 110
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 125
Dystonic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 125
Nausea / vomiting	adult	25–50 mg	IV/IM	not captured	standing	page 486
Nausea / vomiting	peds	1 mg/kg	IV/IM	not captured	standing	page 486
Other	adult	25–50 mg	IV/IM	not captured	standing	page 486
Other	adult	25–50 mg	IV/IM	not captured	standing	page 486
Other	peds	1 mg/kg	IV/IM	not captured	standing	page 486
Other	peds	1 mg/kg	IV/IM	not captured	standing	page 486
Procedural sedation	adult	25–50 mg	IV/IM	not captured	standing	page 486
Procedural sedation	peds	1 mg/kg	IV/IM	not captured	standing	page 486

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiogenic shock	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 489
Cardiogenic shock	peds	2–20 mcg/kg	IV/IO	not captured	standing	page 489
Hypotension / shock	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 489
Hypotension / shock	peds	2–20 mcg/kg	IV/IO	not captured	standing	page 489
Sepsis	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 489
Sepsis	peds	2–20 mcg/kg	IV/IO	not captured	standing	page 489
Trauma / hemorrhage	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 489
Trauma / hemorrhage	peds	2–20 mcg/kg	IV/IO	not captured	standing	page 489

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.5 mg	IM	not captured	standing	page 493
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	page 493
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	page 493
Bradycardia	adult	2–10 mcg	not captured	not captured	standing	page 493
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	page 493
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	page 493

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1 mcg/kg	IV/IM	not captured	standing	page 66
Mild to moderate pain	adult	2 mcg/kg	IN	not captured	standing	page 136
Mild to moderate pain	peds	1 mcg/kg	IV/IM	not captured	standing	page 66
Mild to moderate pain	peds	2 mcg/kg	IN	not captured	standing	page 136

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	20–80 mg	IV	not captured	standing	page 74
CHF / pulmonary edema	peds	0.5–1 mg/kg	IV	not captured	standing	page 74

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IO	not captured	standing	page 500
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IO	not captured	standing	page 500
Beta-blocker / calcium-channel-blocker overdose	peds	1 mg	IV/IO	not captured	standing	page 500
Beta-blocker / calcium-channel-blocker overdose	peds	1 mg	IV/IO	not captured	standing	page 500
Hypoglycemia	adult	1 mg	IM	not captured	standing	page 500
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	page 500

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5–10 mg	IM	not captured	standing	page 554

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	100 mg	IV/IM	not captured	standing	page 552
Asthma / bronchospasm	adult	100 mg	IV/IM	not captured	standing	page 552

Hydroxyzine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25 mg	IM	not captured	standing	page 550
Allergic reaction	adult	25 mg	IM	not captured	standing	page 550
Allergic reaction	peds	0.5 mg/kg	IM	not captured	standing	page 550
Allergic reaction	peds	0.5 mg/kg	IM	not captured	standing	page 550
Anaphylaxis	adult	25 mg	IM	not captured	standing	page 550
Anaphylaxis	peds	0.5 mg/kg	IM	not captured	standing	page 550
Nausea / vomiting	adult	25 mg	IM	not captured	standing	page 550
Nausea / vomiting	peds	0.5 mg/kg	IM	not captured	standing	page 550
Other	adult	25 mg	IM	not captured	standing	page 550
Other	adult	25 mg	IM	not captured	standing	page 550
Other	peds	0.5 mg/kg	IM	not captured	standing	page 550
Other	peds	0.5 mg/kg	IM	not captured	standing	page 550
Procedural sedation	adult	25 mg	IM	not captured	standing	page 550
Procedural sedation	peds	0.5 mg/kg	IM	not captured	standing	page 550

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.5 mg	NEB	not captured	standing	page 502
Anaphylaxis	peds	0.25 mg	NEB	not captured	standing	page 502
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	page 502
Asthma / bronchospasm	peds	0.25 mg	NEB	not captured	standing	page 502
Burns	adult	0.5 mg	NEB	not captured	standing	page 502
Burns	peds	0.25 mg	NEB	not captured	standing	page 502
CHF / pulmonary edema	adult	0.5 mg	NEB	not captured	standing	page 502
CHF / pulmonary edema	peds	0.25 mg	NEB	not captured	standing	page 502
COPD	adult	0.5 mg	NEB	not captured	standing	page 502
COPD	peds	0.25 mg	NEB	not captured	standing	page 502
Other	adult	0.5 mg	NEB	not captured	standing	page 502
Other	peds	0.25 mg	NEB	not captured	standing	page 502

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 136
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 136
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	page 136
Mild to moderate pain	peds	0.5 mg/kg	IM	not captured	standing	page 136

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1–2 mg/kg	IV	not captured	standing	page 542
RSI induction	peds	1–2 mg/kg	IV	not captured	standing	page 542

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1–2 mg	IV/IM	not captured	standing	page 505
Other	adult	0.05 mg/kg	IV	not captured	standing	page 505
Procedural sedation	adult	1–2 mg	IV	not captured	standing	page 505
Procedural sedation	peds	0.05–0.1 mg/kg	IV	not captured	standing	page 505
Status epilepticus	adult	2–4 mg	IV/IM	not captured	standing	page 505
Status epilepticus	peds	0.1 mg/kg	IV/IM	not captured	standing	page 505

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	1–2 g	IV	not captured	standing	page 508
Asthma / bronchospasm	peds	25–50 mg/kg	IV	not captured	standing	page 508
Eclampsia / pre-eclampsia	adult	2 g	IV	not captured	standing	page 508
VF / pulseless VT	adult	1–2 g	IV	not captured	standing	page 508
VF / pulseless VT	peds	25–50 mg/kg	IV	not captured	standing	page 508

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	5 mg	IV	not captured	standing	page 510

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	5 mg	IV	not captured	standing	page 66
Agitation	adult	0.1 mg/kg	IV/IM	not captured	standing	page 115
Procedural sedation	adult	0.1 mg/kg	IV	not captured	standing	page 513
Procedural sedation	adult	2.5 mg	IV	not captured	standing	page 512
Procedural sedation	peds	0.05–0.1 mg/kg	IV	not captured	standing	page 513
Procedural sedation	peds	0.1 mg/kg	IV	not captured	standing	page 512
Procedural sedation	peds	0.2 mg/kg	IN	not captured	standing	page 513

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–3 mg	IV	not captured	standing	page 515
STEMI	adult	2.5–5 mg	IV	not captured	standing	page 515
STEMI	adult	5–10 mg	IM	not captured	standing	page 515
STEMI	peds	0.1–0.2 mg/kg	IV	not captured	standing	page 515
STEMI	peds	0.1–0.2 mg/kg	IM	not captured	standing	page 515

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.5 mg	IV	not captured	standing	page 518
Opioid overdose	adult	2 mg	IN	not captured	standing	page 518
Opioid overdose	peds	0.1 mg/kg	IV	not captured	standing	page 518
Opioid overdose	peds	0.2 mg/kg	IN	not captured	standing	page 518
Other	adult	0.5 mg	IV	not captured	standing	page 518
Other	peds	0.1 mg/kg	IV	not captured	standing	page 518
Other	peds	0.2 mg/kg	IN	not captured	standing	page 518

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	page 66
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 74
STEMI	adult	0.4 mg	SL	not captured	standing	page 70

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiogenic shock	adult	0.1–0.5 mcg/kg	IV	not captured	standing	page 525
Cardiogenic shock	peds	0.05–0.1 mcg/kg	IV	not captured	standing	page 525
Hypotension / shock	adult	0.1–0.5 mcg/kg	IV	not captured	standing	page 525
Hypotension / shock	peds	0.05–0.1 mcg/kg	IV	not captured	standing	page 525
Sepsis	adult	0.1–0.5 mcg/kg	IV	not captured	standing	page 525
Sepsis	peds	0.05–0.1 mcg/kg	IV	not captured	standing	page 525
Trauma / hemorrhage	adult	0.1–0.5 mcg/kg	IV	not captured	standing	page 525
Trauma / hemorrhage	peds	0.05–0.1 mcg/kg	IV	not captured	standing	page 525

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	page 134
Nausea / vomiting	adult	4 mg	PO	not captured	standing	page 134
Nausea / vomiting	peds	0.1 mg/kg	IV/IM	not captured	standing	page 134
Nausea / vomiting	peds	4 mg	PO	not captured	standing	page 134

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	page 129
Hypoglycemia	peds	15 g	PO	not captured	standing	page 129

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	0.6 g	IM	not captured	standing	page 263
Organophosphate poisoning	adult	1–2 g	IV	not captured	standing	page 263

Prednisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	60 mg	PO	not captured	standing	page 532
Allergic reaction	peds	1–2 mg/kg	PO	not captured	standing	page 532
Anaphylaxis	adult	60 mg	PO	not captured	standing	page 532
Anaphylaxis	peds	1–2 mg/kg	PO	not captured	standing	page 532
Asthma / bronchospasm	adult	60 mg	PO	not captured	standing	page 532
Asthma / bronchospasm	peds	1–2 mg/kg	PO	not captured	standing	page 532

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Croup	peds	0.5 mL	NEB	not captured	standing	page 493
Other	adult	5 mg	NEB	not captured	standing	page 493
Other	peds	0.5 mL	NEB	not captured	standing	page 493
Other	peds	0.5 mL	NEB	not captured	standing	page 493

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	1 mEq/kg	IV	not captured	standing	page 177
Hyperkalemia	adult	1 mEq/kg	IV	not captured	standing	page 534
Hyperkalemia	peds	1 mEq/kg	IV	not captured	standing	page 534
Other	adult	1 mEq/kg	IV	not captured	standing	page 534
Other	adult	1 mEq/kg	IV	not captured	standing	page 534
Other	peds	1 mEq/kg	IV	not captured	standing	page 534
Other	peds	1 mEq/kg	IV	not captured	standing	page 534
Tricyclic overdose	adult	50 mEq	IV	not captured	standing	page 260

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	page 544
RSI induction	peds	2 mg/kg	IV	not captured	standing	page 544

Vasopressin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	40 unit	IV	not captured	standing	page 538

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.04–0.06 mg/kg	IV	not captured	standing	page 548

Ziprasidone

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10–20 mg	IM	not captured	standing	page 540
Agitation	adult	10–20 mg	IM	not captured	standing	page 540
Other	adult	10–20 mg	IM	not captured	standing	page 540
Other	adult	10–20 mg	IM	not captured	standing	page 540

Cite this

Old Dominion EMS Alliance, Inc., United States EMS Protocol Census. 190 dose entries, effective 2026-06-17.

https://protoquiz.com/census/agencies/old-dominion-ems-alliance/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.